Which hedge funds own CHRS? COHERUS ONCOLOGY INC, Q2 2026 13F holders

16 tracked hedge funds disclosed a position in CHRS (COHERUS ONCOLOGY INC) in their Q2 2026 13F filings, worth $18.6m in total. The largest holder by portfolio weight is CM Management, LLC at 1.9% of its book. 2 opened a new position this quarter: Spark Investment Management LLC, EntryPoint Capital, LLC. 4 exited: Propel Bio Management, LLC, NINE MASTS CAPITAL Ltd, Marshall Wace, LLP.

16

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

2

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

4

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$59.0k

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$2.9m

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$18.6m

Combined value

Sum of the holders' reported positions in the security.

1.3%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.